The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multimodal AI using host, tumor, and ghost biomarker for predicting immunotherapy efficacy in NSCLC.
 
Vanja Miskovic
Honoraria - Novartis
 
Marta Brambilla
Travel, Accommodations, Expenses - Lilly
 
Laura Mazzeo
Honoraria - MSD; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; LEO Pharma
 
Roberto Ferrara
Consulting or Advisory Role - AstraZeneca; BeiGene; BMSi; Daiichi Sankyo; Johnson & Johnson; MSD
 
Cecilia Silvestri
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Alberto Ferrarin
Honoraria - Novartis
 
Cristina Maria Licciardello
No Relationships to Disclose
 
Gabriella Abolalfio
No Relationships to Disclose
 
Paola Portararo
No Relationships to Disclose
 
Anna Zanichelli
No Relationships to Disclose
 
Beshoy Guirges
No Relationships to Disclose
 
Leonardo Provenzano
Speakers' Bureau - Gilead Sciences; Novartis; Pfizer
 
Margherita Ruggirello
No Relationships to Disclose
 
Monica Ganzinelli
No Relationships to Disclose
 
Teresa Beninato
Honoraria - MSD
Travel, Accommodations, Expenses - Lilly; MSD; Pfizer; Sanofi
 
Mario Occhipinti
Honoraria - AstraZeneca; BMSi; MSD
Consulting or Advisory Role - AstraZeneca; BMSi; MSD
Travel, Accommodations, Expenses - Lilly
 
Claudia Proto
Honoraria - AstraZeneca; BMSi; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Janssen; MSD; Roche; Sanofi
Research Funding - AstraZeneca (Inst); BMSi (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; MSD; Roche
 
Giuseppe Lo Russo
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Jhonson and Jhonson; Lilly; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; REGENERON; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MSD Oncology; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; MSD; Roche
 
Sabina Sangaletti
No Relationships to Disclose
 
Arsela Prelaj
Honoraria - AstraZeneca; BMS; BMS; Janssen
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Lilly (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Janssen